Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Apolipoprotein E (apoE) is crucial for cholesterol transport and has anti-atherogenic properties.
• Apolipoprotein A-I (apoA-I) is the primary protein component of high-density lipoprotein (HDL) and plays a key role in reverse cholesterol transport.
• Over-expression of human apoA-I in mice leads to increased human apoA-I-rich HDL particles.

Purpose of the Study:

• To investigate the mechanism behind the observed decrease in plasma apolipoprotein E (apoE) levels in mice over-expressing the human apolipoprotein A-I (apoA-I) gene.
• To determine whether the reduction in apoE is due to displacement from HDL particles or altered gene expression.

Main Methods:

• Quantitative analysis of plasma apoE and apoB levels in wild-type (WT) and apoA-I transgenic (apoAI-Tg) mice.
• Measurement of hepatic apoE and apoA-I mRNA levels using quantitative PCR.
• Assessment of apoE synthesis in hepatocytes from WT and apoAI-Tg mice.

Main Results:

• Plasma apoE levels were 2-3 fold lower in apoAI-Tg mice compared to WT mice, while apoB levels remained unchanged.
• Hepatic apoE mRNA levels were significantly decreased (3-fold) in apoAI-Tg mice, indicating reduced gene expression.
• Hepatocyte studies confirmed lower apoE synthesis in apoAI-Tg mice, supporting the gene expression hypothesis.

Conclusions:

• The reduction in plasma apoE in apoA-I transgenic mice is primarily caused by decreased hepatic apoE gene expression, not by displacement of apoE from HDL particles.
• The integration site of the human apoA-I transgene may influence apoE gene expression, suggesting a potential locus affecting apoE regulation.
• Further identification of this genomic locus could enhance understanding of apoE gene regulation.